Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation

References

• Brown, R.A., Adkins, D., Khoury, H., Vij, R., Goodnough, Shenoy, S. and Di Persio, J.F. (1999) "Long term follow up of high risk allogeneic peripheral blood stem cell transplant recipients: graft versus host disease and transplant related mortality", J. Clin. Oncol. 17, 806–812.
   PubMed Web of Science ®Google Scholar
• Slavin, S., Nagler, A., Naparstek, E., et al. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91, 756–763.
   PubMed Web of Science ®Google Scholar
• Khouri, IF., Keating, M., Korbling, M., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", J. Clin. Oncol. 16, 2817–2824.
   PubMed Web of Science ®Google Scholar
• Mohty, M., Faucher, C., Vey, N., et al. (2000) "High rate of secondary viral and bacterial infections in patients under-going allogeneic bone marrow mini-transplantation", Bone Marrow Transplant 26, 251–255.
   PubMed Web of Science ®Google Scholar
• Martino, R., Caballero, M.D., Canals, C., et al. (2001) "Reduced-intensity conditioning reudces the risk of severe infections after allogeneic peripheral blood stem cell transplantation", Bone Marrow Transplant 28, 341–347.
   PubMed Web of Science ®Google Scholar
• Maraninchi, D., Gluckman, E., Blaise, D., et al. (1987) "Impact of T-cell depletion on outcome of allogeneic bone marrow tranplantation for standard-risk leukaemias", Lancet 2, 175–178.
   PubMed Web of Science ®Google Scholar
• Curtis, R.E., Rowlings, P.A., Deeg, H.J., et al. (1997) "Solid cancers after bone marrow transplantation", N. Engl. J. Med. 336, 897–904.
   PubMed Web of Science ®Google Scholar
• Dupont, B. and Yang, S.Y. (1994) "Histocompatibility", In: Forman, S.J., Blume, KG. and Thomas, E.D., eds, Bone Marrow Transplant (Blaskwell Scientific Publications, Boston, MA), pp 22–40.
   Google Scholar
• Small, TN., Keever, C.A., Weiner-Feddus, S., et al. (1990) "B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitula-tion of normal B-cell ontogeny", Blood 76, 1647–1656.
   PubMed Web of Science ®Google Scholar
• Stelzer, G.T., Marti, G., Hurley, A., et al. (1997) "U:S:Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures", Cytometry 30, 214–230.
   PubMedGoogle Scholar
• Maury, S., Mary, J.Y., Rabian, C., et al. (2001) "Prolonged immune deficiency following allogeneic stem cell transplan-tation: risk factors and complications in adult patients", Br. J. Haematol. 115, 630–641.
   PubMed Web of Science ®Google Scholar
• Glucksberg, H., Storb, R., Fefer, A., et al. (1974) "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors", Transplantation 18, 295–304.
   PubMed Web of Science ®Google Scholar
• Shulman, H.M., Sullivan, K.M., Weiden, PI., et al. (1980) "Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients", Am. J. Med. 69, 204–211.
   PubMed Web of Science ®Google Scholar
• Kaplan, E.L. and Meier, P. (1958) "Nonparametric esti-mation from incomplete observations", J. Am. Stat. Soc. 53, 457–481.
   Web of Science ®Google Scholar
• Friedman, TM., Varadi, G., Hopely, D.D., et al. (2001) "Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches", Biol. Blood Marrow Transplant 7, 656–664.
   PubMed Web of Science ®Google Scholar
• Nakai, K., Kanda, Y., Mineishi, S., et al. (2002) "Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin", Bone Marrow Transplant 29, 237–241.
   PubMed Web of Science ®Google Scholar
• Savage, W.J., Bleesing, J.J.H., Douek, D., et al. (2001) "Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism", Bone Marrow Transplant 28, 463–471.
   PubMed Web of Science ®Google Scholar
• Chao, NE, Liu, C.X., Rooney, B., et al. (2002) "Nonmyelo-ablative regimen preserves Niches allowing for peripheral expansion of donor T-cell", Biol. Blood Marrow Transplant 8, 249–256.
   PubMed Web of Science ®Google Scholar
• De Gast, CC., Verdonck, L.F., Middeldorp, J.M., et al. (1985) "Recovery of T-cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cell in the graft", Blood 66, 428–431.
   PubMed Web of Science ®Google Scholar
• Mackall, CI., Granger, L., Sheard, MA., et al. (1993) "T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny", Blood 82, 2585–2594.
   PubMed Web of Science ®Google Scholar
• Roux, E., Dumont-Girard, F., Starobinski, M., et al. (2000) "Recovery of immune reactivity after T cell depleted bone marrow transplantation depends on thymic activity", Blood 96, 2299–2303.
   PubMed Web of Science ®Google Scholar
• Ottinger, H.D., Beelen, D.W., Scheulen, B., Schaefer, U.W. and Grosse-Wilde, H. (1996) "Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow", Blood 88, 2775–2779.
   PubMed Web of Science ®Google Scholar
• Mossad, S.B., Avery, R.K., Longworth, DI., et al. (2001) "Infectious complications within the first year after non-myeloablative allogeneic peripheral blood stem cell transplantation", Bone Marrow Transplant 28, 491–495.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S., Mackinnon, S., Chopra, R., et al. (2002) "High incidence of Cytomegalovirus infection after non-myeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution", Blood 99, 4357–4363.
   PubMed Web of Science ®Google Scholar
• Perez-Simon, J.A., Kottaridis, P.D. and Martino, R. (2002) "Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders", Blood 100, 3121–3127.
   PubMed Web of Science ®Google Scholar
• Bornhauser, M., Thiede, C., Schuler, U., et al. (2000) "Dose-reduced conditioning for allogenic blood stem cell transplan-tation: durable engraftment without antithymocyte globulin", Bone Marrow Transplant 26, 119–125.
   PubMed Web of Science ®Google Scholar
• Graber, C., De Almeida, K.N.F., Childs, R., et al. (2001) "CMV reactivation in nonmyeloablative HSCT", Bone Marrow Transplant 27, 775.
   PubMed Web of Science ®Google Scholar
• McSweeney, PA., Niederwieser, D., Shizuru, J.A., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects", Blood 97, 3390–3400.
   PubMed Web of Science ®Google Scholar
• Sarmiento, J.M., Dockrell, D.H., Schwab, T.R., Munn, S.R. and Paya, CV. (2000) "Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients", Clin. Transplant 14, 136–138.
   PubMed Web of Science ®Google Scholar
• Junghanss, C., Marr, K.A., Carter, R.A., et al. (2002) "Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study", Biol. Blood Marrow Transplant 8, 512–520.
   PubMed Web of Science ®Google Scholar
• Hagen, E.A., Stern, H., Porter, D., Duffy, K., Foley, K., Luger, S., Schuster, S.J., et al. (2003) "High rate of invasive fungal infections following nonmyeloablative allogeneic transplan-tation", Clin. Infect. Dis. 36, 9–15.
   PubMed Web of Science ®Google Scholar